Pharmacological manipulation of gain-of-function and dominant-negative mechanisms in rhodopsin retinitis pigmentosa

Human Molecular Genetics

Volumn 17, Issue 19, 2008, Pages 3043-3054

  Mendes, Hugo F ^a   Cheetham, Michael E ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 3; CELASTROL; CHAPERONE; LACTATE DEHYDROGENASE; MAMMALIAN TARGET OF RAPAMYCIN; OPSIN; RADICICOL; RAPAMYCIN; RETINOID; RHODOPSIN; TANESPIMYCIN; TREHALOSE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE MICROSCOPY; INHIBITION KINETICS; MUTANT; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; RETINITIS PIGMENTOSA; WESTERN BLOTTING;

AUTOPHAGY; CELL LINE, TUMOR; GENES, DOMINANT; HUMANS; INORGANIC CHEMICALS; OPSIN; ORGANIC CHEMICALS; PROTEIN CONFORMATION; PROTEIN FOLDING; RETINITIS PIGMENTOSA; RETINOIDS;

EID: 52949134162     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddn202     Document Type: Article

References (40)

1. Dryja, T.P., McGee, T.L., Hahn, L.B., Cowley, G.S., Olsson, J.E., Reichel, E., Sandberg, M.A. and Berson, E.L. (1990) Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa. N. Engl. J. Med., 323, 1302-1307.
2. Sung, C.H., Schneider, B.G., Agarwal, N., Papermaster, D.S. and Nathans, J. (1991) Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Proc. Natl Acad. Sci. USA 88, 8840-8844.
3. Sung, C.H., Davenport, C.M. and Nathans, J. (1993) Rhodopsin mutations responsible for autosomal dominant retinitis pigmentosa. Clustering of functional classes along the polypeptide chain. J. Biol. Chem., 268, 26645-26649.
4. Kaushal, S. and Khorana, H.G. (1994) Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry, 33, 6121-6128.
5. Mendes, H.F., van der Spuy, J., Chapple, J.P. and Cheetham, M.E. (2005) Mechanisms of cell death in rhodopsin retinitis pigmentosa: Implications for therapy. Trends Mol. Med., 11, 177-185.
6. Wilson, J.H. and Wensel, T.G. (2003) The nature of dominant mutations of rhodopsin and implications for gene therapy. Mol. Neurobiol., 28, 149-158.
7. Humphries, M.M., Rancourt, D., Farrar, G.J., Kenna, P., Hazel, M., Bush, R.A., Sieving, P.A., Sheils, D.M., McNally, N., Creighton, P. et al. (1997) Retinopathy induced in mice by targeted disruption of the rhodopsin gene. Nat. Genet., 15, 216-219.
8. Lem, J., Krasnoperova, N.V., Calvert, P.D., Kosaras, B., Cameron, D.A., Nicolo, M., Makino, C.L. and Sidman, R.L. (1999) Morphological, physiological, and biochemical changes in rhodopsin knockout mice. Proc. Natl Acad. Sci. USA, 96, 736-741.
9. Saliba, R.S., Munro, P.M., Luthert, P.J. and Cheetham, M.E. (2002) The cellular fate of mutant rhodopsin: Quality control, degradation and aggresome formation. J. Cell Sci., 115, 2907-2918.
10. Illing, M.E., Rajan, R.S., Bence, N.F. and Kopito, R.R. (2002) A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system. J. Biol. Chem., 277, 34150-34160.
11. Tam, B.M. and Moritz, O.L. (2006) Characterization of rhodopsin P23H-induced retinal degeneration in a Xenopus laevis model of retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci., 47, 3234-3241.
12. Lin, J.H., Li, H., Yasumura, D., Cohen, H.R., Zhang, C., Panning, B., Shokat, K.M., Lavail, M.M. and Walter, P. (2007) IRE1 signaling affects cell fate during the unfolded protein response. Science, 318 944-949.
13. Rajan, R.S. and Kopito, R.R. (2005) Suppression of wild-type rhodopsin maturation by mutants linked to autosomal dominant retinitis pigmentosa. J. Biol. Chem., 280, 1284-1291.
14. Kopito, R.R. (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol., 10, 524-530.
15. Balch, W.E., Morimoto, R.I., Dillin, A. and Kelly, J.W. (2008) Adapting proteostasis for disease intervention. Science, 319, 916-919.
16. Li, T., Sandberg, M.A., Pawlyk, B.S., Rosner, B., Hayes, K.C., Dryja, T.P. and Berson, E.L. (1998) Effect of vitamin A supplementation on rhodopsin mutants threonine-17 → methionine and proline-347 → serine in transgenic mice and in cell cultures. Proc. Natl Acad. Sci. USA 95, 11933-11938.
17. Noorwez, S.M., Kuksa, V., Imanishi, Y., Zhu, L., Filipek, S., Palczewski, K. and Kaushal, S. (2003) Pharmacological chaperone-mediated in vivo folding and stabilization of the P23H-opsin mutant associated with autosomal dominant retinitis pigmentosa. J. Biol. Chem., 278, 14442-14450.
18. Noorwez, S.M., Malhotra, R., McDowell, J.H., Smith, K.A., Krebs, M.P. and Kaushal, S. (2004) Retinoids assist the cellular folding of the autosomal dominant retinitis pigmentosa opsin mutant P23H. J. Biol. Chem., 279, 16278-16284.
19. Zeitlin, P.L., Diener-West, M., Rubenstein, R.C., Boyle, M.P., Lee, C.K. and Brass-Ernst, L. (2002) Evidence of CFTR function in cystic fibrosis after systemic administration of 4-phenylbutyrate. Mol. Ther., 6, 119-126.
20. Kosmaoglou, M., Schwarz, N., Bett, J.S. and Cheetham, M.E. (2008) Molecular chaperones and photoreceptor function. Prog. Retin. Eye Res., in press. PMID: 18490186.
21. Westerheide, S.D., Bosman, J.D., Mbadugha, B.N., Kawahara, T.L., Matsumoto, G., Kim, S., Gu, W., Devlin, J.P., Silverman, R.B. and Morimoto, R.I. (2004) Celastrols as inducers of the heat shock response and cytoprotection. J. Biol. Chem., 279, 56053-56060.
22. Kiaei, M., Kipiani, K., Petri, S., Chen, J., Calingasan, N.Y. and Beal, M.F. (2005) Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis. Neurodegener. Dis., 2, 246-254.
23. Sittler, A., Lurz, R., Lueder, G., Priller, J., Lehrach, H., Hayer-Hartl, M.K., Hartl, F.U. and Wanker, E.E. (2001) Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease. Hum. Mol. Genet., 10, 1307-1315.
24. Waza, M., Adachi, H., Katsuno, M., Minamiyama, M., Sang, C., Tanaka, F., Inukai, A., Doyu, M. and Sobue, G. (2005) 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. Nat. Med., 11, 1088-1095.
25. Ravikumar, B., Duden, R. and Rubinsztein, D.C. (2002) Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum. Mol. Genet., 11, 1107-1117.
26. Ravikumar, B., Vacher, C., Berger, Z., Davies, J.E., Luo, S., Oroz, L.G., Scaravilli, F., Easton, D.F., Duden, R., O'Kane, C.J. and Rubinsztein, D.C. (2004) Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet., 36, 585-595.
27. Westhoff, B., Chapple, J.P., van der Spuy, J., Höhfeld, J. and Cheetham, M.E. (2005) HSJ1 is a neuronal shuttling factor for the sorting of chaperone clients to the proteasome. Curr. Biol., 15 1058-1064.
28. Bennett, E.J., Bence, N.F., Jayakumar, R. and Kopito, R.P. (2005) Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. Mol. Cell., 17, 351-365.
29. Sarkar, S., Davies, J.E., Huang, Z., Tunnacliffe, A. and Rubinsztein, D.C. (2007) Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J. Biol. Chem., 282, 5641-5652.
30. Berson, E.L., Rosner, B., Sandberg M.A., Hayes, K.C., Nicholson, B.W., Weigel-DiFranco, C. and Willett, W. (1993) A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch. Ophthalmol., 111, 761-772.
31. Sibulesky, L., Hayes, K.C., Pronczuk, A., Weigel-DiFranco, C., Rosner, B. and Berson, E.L. (1999) Safety of <7500 RE (<25000 IU) vitamin A daily in adults with retinitis pigmentosa. Am. J. Clin. Nutr., 69, 656-663.
32. Bauernfeind, J.C. (1980). Vitamin A - application technology. Food Nutr., 6, 10-20.
33. Tam, B.M. and Moritz, O.L. (2007) Dark rearing rescues P23H rhodopsin-induced retinal degeneration in a transgenic Xenopus laevis model of retinitis pigmentosa: A chromophore-dependent mechanism characterized by production of N-terminally truncated mutant rhodopsin. J. Neurosci., 27, 9043-9053.
34. Samardzija, M., Wenzel, A., Naash, M., Remé, C.E. and Grimm, C. (2006) Rpe65 as a modifier gene for inherited retinal degeneration. Eur. J. Neurosci., 23, 1028-1034.
35. Noorwez, S.M., Ostrov, D.A., McDowell, J.H., Krebs, M.P. and Kaushal, S. (2008) A high-throughput screening method for small-molecule pharmacological chaperones of misfolded rhodopsin. Invest. Ophthalmol. Vis. Sci., 49, 3224-3230.
36. Burlina, A.B., Ogier, H., Korall, H. and Trefz, F.K. (2001) Long-term treatment with sodium phenylbutyrate in ornithine transcarbamylase-deficient patients. Mol. Genet. Metab., 72, 351-355.
37. Rubenstein, R.C., Egan, M.E. and Zeitlin, P.L. (1997) In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR. J. Clin. Invest., 100, 2457-2465.
38. Berger, Z., Ravikumar, B., Menzies, F.M., Oroz, L.G., Underwood, B.R., Pangalos, M.N., Schmitt, I., Wullner, U., Evert, B.O., O'Kane, C.J. and Rubinsztein, D.C. (2006) Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum. Mol. Genet., 15, 433-442.
39. Kaushal, S. (2007) Effect of rapamycin on the fate of P23H opsin associated with retinitis pigmentosa (an American Ophthalmological Society thesis). Trans. Am. Ophthalmol. Soc., 104, 517-529.
40. Novoselova, T.V., Margulis, B.A., Novoselov, S.S., Sapozhnikov, A.M., van der Spuy, J., Cheetham, M.E. and Guzhova, I.V. (2005) Treatment with extracellular HSP70/HSC70 protein can reduce polyglutamine toxicity and aggregation. J. Neurochem., 94, 597-606.